Cardiol Therapeutics Inc. (CRDL) stock
CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.86−0.02 (-2.28%)
Close on Nov 20, 2026Market cap $86.48MP/E –Yield –
Cardiol Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Cardiol Therapeutics's total assets was C$23.62M at Dec 31, 2025. For fiscal 2025 it was C$23.62M, down 25.9% from the year before. The highest annual figure on record is C$87.88M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | C$23.62M | -25.9% |
| FY2024 | Dec 31, 2024 | C$31.86M | -13.2% |
| FY2023 | Dec 31, 2023 | C$36.70M | -40.8% |
| FY2022 | Dec 31, 2022 | C$62.03M | -29.4% |
| FY2021 | Dec 31, 2021 | C$87.88M | +452.9% |
| FY2020 | Dec 31, 2020 | C$15.89M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | C$23.62M | -73.1% |
| Q4 FY2024 | Dec 31, 2024 | C$31.86M | +100.5% |
| Q4 FY2023 | Dec 31, 2023 | C$36.70M | – |
| Q4 FY2022 | Dec 31, 2022 | C$62.03M | – |
| Q4 FY2021 | Dec 31, 2021 | C$87.88M | – |
| Q4 FY2020 | Dec 31, 2020 | C$15.89M | – |
See a number that looks wrong?